, Tracking Stock Market Picks
Enter Symbol:
Dendreon Corporation (DNDN) [hlAlert]

down 99.40 %

Dendreon Corporation (DNDN) rated Buy with price target $33 by Lazard Capital Mkts

Posted on: Wednesday,  Apr 29, 2009  8:25 AM ET by Lazard Capital Mkts

Lazard Capital Mkts rated Buy Dendreon Corporation (NASDAQ: DNDN) on 04/29/2009. Previously Lazard Capital Mkts rated Buy Dendreon Corporation (NASDAQ: DNDN) on
04/20/2009., when the stock price was $18.62. Since then, Dendreon Corporation has lost 99.41% as of 11/14/2014's recent price of $0.11.
If you would have followed the previous Lazard Capital Mkts's recommendation on DNDN, you would have lost 99.4% of your investment in 2034 days.

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. Through the use of antigen engineering and proprietary cell separation technologies, Dendreon develops therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer. In addition to its products for cancer, Dendreon also intends to pursue the application of its technologies in the fields of autoimmune diseases, allergies and infectious diseases.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Lazard Capital Markets’ goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Lazard Capital Markets’ industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2009 8:25 AM Buy
27.01 33.00
as of 12/31/2009
1 Week up  32.46 %
1 Month up  28.20 %
3 Months up  25.22 %
1 YTD up  29.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/20/2009 8:25 AM Buy
18.62 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy